United Arab Emirates (UAE) Insulin Delivery Devices Market Overview, 2028

The market for insulin delivery devices in the United Arab Emirates has grown significantly, owing to many important factors. In order to begin, the prevalence of diabetes in the United Arab Emirates has progressively increased as a result of lifestyle changes such as sedentary habits, bad diets, and an ageing population. This rise in diabetes incidence has boosted the country's desire for insulin delivery systems. Furthermore, technological improvements in diabetes control have considerably contributed to the market's growth. More improved insulin administration technologies, such as insulin pens, pumps, and continuous glucose monitoring (CGM) systems, have given patients more convenient and effective ways to manage their disease. These devices provide increased dosage precision, greater control over insulin administration, and enhanced monitoring of glucose levels, thus driving their adoption among patients and healthcare providers in the United Arab Emirates. The government's dedication to upgrading healthcare facilities and services is another driving element behind the growth of the insulin delivery device market in the United Arab Emirates. The United Arab Emirates government has actively promoted health awareness campaigns and invested in healthcare facilities, resulting in improved access to diabetes care and treatment. Furthermore, the government's initiatives to make vital pharmaceuticals and medical devices more inexpensive and accessible have contributed to market growth. In addition, the desire for home-based treatment and self-management among diabetics has increased demand for insulin delivery devices in the United Arab Emirates. Patients increasingly appreciate the ease and autonomy given by these devices, which allow them to deliver insulin dosages at home without having to return to the hospital on a regular basis. This transition to patient-centred care aligns with the growing trend of empowering individuals to actively manage their health conditions, thus driving the adoption of insulin delivery devices. According to the research report "United Arab Emirates Insulin Delivery Devices Market Overview, 2028," published by Bonafide Research, the United Arab Emirates Insulin Delivery Devices market is predicted to grow with more than 5.50% CAGR from 2023 to 2028. In insulin delivery, there is a substantial trend towards technological improvements. The United Arab Emirates healthcare sector has embraced advances in smart insulin administration devices. Adoption of linked devices, such as Bluetooth-enabled insulin pens and pumps that sync data with cellphones or cloud-based platforms, is one example. These technologies give patients and healthcare provider’s real-time access to critical information, including insulin dosage history and blood glucose levels, allowing for better decision-making and more personalised care. The emphasis on patient-centric treatment and improved user experience is another important trend in the United Arab Emirates insulin delivery device industry. Manufacturers are increasingly emphasising the importance of building products that prioritise user comfort, ease of use, and discretion. This has led to the development of sleeker, more compact insulin pens, needle-free injection systems, and wearable insulin delivery devices like patches or pumps, providing patients with discreet and convenient options for insulin administration. Furthermore, the United Arab Emirates healthcare scene is seeing an increase in telemedicine and remote patient monitoring in diabetes management. Remote consultations with healthcare specialists are made possible through the use of telehealth platforms and mobile applications, allowing for prompt assistance and support for diabetes treatment. Patients can receive personalised care and make educated decisions when combined with remote monitoring devices such as CGMs and connected insulin delivery tools, eliminating the need for frequent in-person visits to healthcare institutions.

Based on product market is majorly divided into insulin pens, insulin pumps, insulin pen needles, insulin syringes and others insulin delivery devices (insulin transdermal patches, insulin inhalers, insulin jet injection). Insulin syringes product is expected to grow at rapid pace in United Arab Emirates insulin delivery devices market. Insulin syringes have long been a popular and commonly available form of insulin administration. As of their inexpensive cost in comparison to newer equipment like insulin pumps or continuous glucose monitoring systems, they are an affordable alternative for a larger population in the United Arab Emirates. This affordability contributes to their market's continued demand and rapid growth. Despite the development of newer insulin administration devices, many patients and healthcare practitioners in the United Arab Emirates still use insulin syringes because they are familiar and trusted. Established usage and familiarity frequently contribute to sustained preference, particularly among people who are used to this route of insulin delivery. The United Arab Emirates boasts a diversified population, with people of all ages and ethnic origins. Because of personal preferences, cultural circumstances, or a desire for simpler and more uncomplicated methods, some parts of the population can choose insulin syringes. This wide demographic profile contributes to the ongoing demand for insulin syringes. In terms of end user segment market is categorised into home care, hospitals and clinics and others. Home care end user segment is expected to lead the United Arab Emirates insulin delivery devices market. Diabetes patients benefit from the ease and comfort of home care settings. Patients frequently prefer the comfort and privacy of their own homes for insulin administration, which leads to a preference for insulin delivery systems that allow self-administration. The desire for easy home-based care increases the demand for insulin delivery devices designed for use at home. The progress of insulin delivery systems has resulted in the creation of user-friendly and portable home-use solutions. Insulin pens, pumps, and continuous glucose monitoring systems (CGMs) are increasingly being engineered for simple self-administration and monitoring, allowing for more successful diabetes control at home. In terms of indication segment market includes diabetes, pregnancy, cardiovascular disorders & hypertension, respiratory diseases, hearing disorders, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). Insulin delivery devices are gaining popularity in cardiovascular disorders & hypertension disease monitoring in United Arab Emirates. Diabetes is inextricably connected to cardiovascular disease and high blood pressure. Diabetes patients are more likely to have heart disease and excessive blood pressure. As insulin is such an important component of diabetes management, the use of insulin delivery devices indirectly leads to better blood sugar control, lowering the risk of cardiovascular problems. Healthcare providers understand the value of a comprehensive approach to illness management, particularly when many chronic disorders coexist. Insulin delivery systems contribute to a more thorough awareness of a patient's health status through their monitoring capabilities and data insights. This integrated strategy aids in the management of diabetes as well as cardiovascular diseases and hypertension, resulting in improved overall health outcomes. Considered in this report: • Geography: United Arab Emirates • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Aspects covered in this report: • United Arab Emirates Insulin Delivery Devices market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product: • Insulin Pens • Insulin Pumps • Insulin Pen Needles • Insulin Syringes • Others Insulin Delivery Devices(Insulin transdermal patches, Insulin inhalers, Insulin jet injection) By End User: • Home Care • Hospitals & Clinics • Others

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Indication: • Diabetes • Pregnancy • Cardiovascular Disorders & Hypertension • Respiratory Diseases • Hearing Disorders • Cancer • Movement Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Insulin Delivery Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.